School of Medicine
Showing 1-100 of 129 Results
-
Deborah Kado
Professor of Medicine (Primary Care and Population Health) and, by courtesy, of Epidemiology and Population Health
BioDr. Kado is a board-certified, fellowship-trained doctor specializing in geriatrics. She serves as co-director of the Stanford Longevity Center. She is a professor of medicine and chief of research for the Geriatrics Section in the Department of Medicine, Division of Primary Care and Population Health. She is also the Director of the Geriatric Research, Education, and Clinical Center (GRECC) at VA Palo Alto Health Care System.
For each patient, Dr. Kado prepares a personalized care plan. Her objective is to help all individuals maintain the best possible health and quality of life as they age.
A special interest of Dr. Kado is bone health. She has conducted extensive research focused on osteoporosis and the related disorder hyperkyphosis.
Since joining the UCLA faculty in 2000, she has received continuous funding for her research from the National Institutes of Health (NIH).
She has over 100 peer-reviewed publications of her research findings in the Journal of Bone and Mineral Research, Osteoporosis International, Journal of Gerontology and Medical Sciences, Journal of Geriatric Oncology, Nature Communications, and other peer-reviewed journals.
In 2007, she defined hyperkyphosis as a new geriatric syndrome. Her discoveries in this field were first featured in the American College or Physician’s premier internal medicine journal Annals of Internal Medicine. Later, they also appeared in a dedicated chapter in UpToDate, the electronic resource providing evidence-based clinical decision support for doctors worldwide.
Prior to coming to Stanford, Dr. Kado practiced at UC San Diego where she started a dedicated osteoporosis clinic for patient care and research. She later broadened her research interests beyond musculoskeletal aging to study other aging-related topics such as the gut microbiome in older men and the effects of cancer treatments on aging in newly diagnosed breast cancer patients.
Dr. Kado is a California native. She trained at UCSF and UCLA. She also earned a Master of Science degree in epidemiology at the UCLA School of Public Health, sponsored by the John Hartford Foundation.
She is a member of the American Geriatrics Society, American Society of Bone and Mineral Research, Gerontological Society of America, The Endocrine Society, and other professional organizations. She co-chairs the NIH National Institute on Aging Workshop for the American Society of Bone and Mineral Research. She also participates in the Bone Health Working Group of the Society for Women’s Health Research. -
James Kahn
Professor of Medicine (General Medical Disciplines), Emeritus
Current Research and Scholarly InterestsMy initial research activities involved antiretroviral and novel therapeutic treatments of HIV infection, understanding elements of HIV pathogenesis associated with acute HIV infection and post exposure prevention. My most recent scholarly activities concentrate on working as a team to capitalize on the data stored in electronic medical records, HIV disease modeling and using electronic medical records for outcome research and developing a mentorship program for early career scientists.
-
Neil M. Kalwani
Clinical Instructor, Medicine - Cardiovascular Medicine
BioNeil Kalwani, MD, MPP is a Clinical Instructor in the Division of Cardiovascular Medicine and Director of Preventive Cardiology at the VA Palo Alto Health Care System. He attended college at Yale University and completed graduate degrees in medicine and public policy at Harvard University. He trained in internal medicine at Brigham and Women’s Hospital before arriving at Stanford in 2018 for fellowship in cardiovascular medicine, during which he served as Chief Fellow. He then completed a postdoctoral fellowship through the Stanford-AHRQ Health Services Research Training Program in the Department of Health Policy. His clinical focus is in general and preventive cardiology and echocardiography. He practices at the VA Palo Alto Health Care System and at Stanford Health Care.
Dr. Kalwani's research focuses on the evaluation of policies and care delivery innovations designed to improve the value of care for patients with cardiovascular disease. -
Afrin N. Kamal, MD MS
Clinical Assistant Professor, Medicine - Gastroenterology & Hepatology
BioAfrin Kamal is a board-certified gastroenterologist, who trained at Washington University in internal medicine, Cleveland Clinic in gastroenterology/hepatology, and most recently Stanford University in esophageal and motility diseases. Afrin shares a clinical passion in esophageal motility diseases with an an overlapping interest in health services and outcomes research.
-
Ahmad Kamal, MD, MS
Clinical Associate Professor (Affiliated), Medicine - Med/Gastroenterology and Hepatology
BioDr. Kamal graduated from the University of California at Irvine in 1995 with a B.S. in Biology and received his M.D. from Harvard Medical School in 1999. He completed his residency in Internal Medicine and fellowship in Gastroenterology at Stanford in 2006, during which time he also earned an MSc in Clinical Epidemiology.
In addition to serving as associate chief of the division of gastroenterology at SCVMC, Dr. Kamal is vice chair of internal medicine and director of the clinical research pathway, an innovative program that provides mentoring and protected time for clinical research to internal medicine residents. He is active in teaching trainees at all levels and received an outstanding mentor award from Stanford's biodesign program.
Dr. Kamal has been named a fellow of the American Gastroenterological Association and has been recognized several times in the "Top Doctors" list. He received the Hospital Quality Institute's C. Duane Dauner Award for his work in specialty care transformation and was one of 6 recipients of Silicon Valley Business Journal's Excellence in Healthcare Award. During the COVID-19 pandemic, he served as Director of Health Systems Preparedness for Santa Clara County and was awarded a Medal for Outstanding Service by the Board of Supervisors.
Dr. Kamal has also been active in clinical and health services research, authoring over 20 peer-reviewed publications, 40 abstracts, and 7 book chapters. -
Vishnu Priya Kanakaveti
Postdoctoral Scholar, Oncology
Current Research and Scholarly InterestsI am interested in elucidating molecular mechanisms of MYC-driven drug resistance and immune evasion in cancer using computational and experimental models.
-
Beverley Kane
Adjunct Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioBeverley Kane, MD, was Board Certified in Family Medicine, then completed fellowships in Ob-Gyn (San Francisco Children's Hosptial) and Sports Medicine (London Univeristy). She has worked in the private practice of sports medicine; in medical informatics, specializing in doctor-patient communication (WebMD); and in stress management with her private practice, Horsensei Equine-Assisted Learning & THerapy (HEALTH). Her latest book, "Equine-imity--Stress Reduction and Emotional Self-Regulation in the Company of Horses," published 27 March 2021, can be seen at http://equine-imity.com/
-
Guson Kang
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
BioDr. Kang is an interventional cardiologist who specializes in the treatment of structural heart disease. He has expertise in complex coronary interventions, transcatheter aortic and mitral valve replacements, transcatheter mitral valve repair, left atrial appendage occlusion, PFO/septal defect closure, alcohol septal ablation, and paravalvular leak closure.
A Bay Area native, he graduated from Stanford University and obtained his medical degree at Yale University. He came back to Stanford to train in internal medicine, cardiology, and interventional cardiology before completing an advanced structural interventions fellowship at Ford Hospital. -
Peter Kao
Associate Professor of Medicine (Pulmonary and Critical Care Medicine)
Current Research and Scholarly InterestsOur research program has several active projects:
1.) Pulmonary Vascular Disease Simvastatin reversed experimental pulmonary hypertension, and is safe for treatment of patients. Blinded clinical trials of efficacy are in progress.
2.) Lung inflammation and regeneration (stem cells)
3.) Lung surfactant rheology and oxidative stress
4.) Gene regulation by RNA binding proteins, NF45 and NF90 through transcriptional and posttranscriptional mechanisms -
Michael S. Kapiloff, MD, PhD
Reinhard Family Professor, Professor (Research) of Ophthalmology and, by courtesy, of Medicine (Cardiovascular Medicine)
Current Research and Scholarly InterestsDr. Michael S. Kapiloff is a faculty member in the Departments of Ophthalmology and Medicine (Cardiovascular Medicine) and a member of the Stanford Cardiovascular Institute. Although Dr. Kapiloff was at one time a Board-Certified General Pediatrician, he is currently involved in full-time basic science and translational research. His laboratory studies the basic molecular mechanisms underlying the response of the retinal ganglion cell and cardiac myocyte to disease. The longstanding interest of his laboratory is the role in intracellular signal transduction of multimolecular complexes organized by scaffold proteins. Recently, his lab has also been involved in the translation of these concepts into new therapies, including the development of new AAV gene therapy biologics for the prevention and treatment of heart failure and for neuroprotection in the eye.
URL to NCBI listing of all published works:
http://www.ncbi.nlm.nih.gov/sites/myncbi/michael.kapiloff.1/bibliography/40252285/public/?sort=date&direction=descending
For more information see Dr. Kapiloff's lab website: http://med.stanford.edu/kapilofflab.html -
Robert Kaplan
Adjunct Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly InterestsHealth services research
Studies on the cost and quality of health care
Health outcome measurement
Social determinants of health -
Shanthi Kappagoda
Clinical Associate Professor, Medicine - Infectious Diseases
Current Research and Scholarly InterestsCompleted a Masters degree in Health Services Research in 2012. Research focused on using network models to develop a clinical research agenda for neglected tropical diseases.
-
Jaya Karnani, MD
Adjunct Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Jaya Karnani practices family medicine in Bay Valley Medical Group’s Hayward office. She attended medical school at Kasturba Medical College in India and completed her residency at the Fort Wayne Medical Education Program in Indiana.
Dr. Karnani is board-certified by the American Board of Family Medicine. She speaks English and Hindi. Dr. Karnani joined Bay Valley Medical Group in 2009. In her spare time, she enjoys cooking, traveling, reading and watching movies. -
David Karpf
Adjunct Clinical Professor, Medicine - Endocrinology, Gerontology, & Metabolism
BioMy specialty within Endocrinology is Metabolic Bone Disease, including both osteoporosis and hypoparathyroidism, as well as other conditions including hyper- and hyo-calcemia, hypercalciuria, Paget's Disease, Osteogenesis Imperfecta, hypophosphatasia, and other metabolic bone diseases, as well as diabetes and thyroid diseases.
-
Maya M. Kasowski
Assistant Professor of Pathology, of Medicine (Pulmonary, Allergy and Critical Care Medicine) and, by courtesy, of Genetics
BioI am a clinical pathologist and assistant professor in the Departments of Medicine, Pathology, and Genetics (by courtesy) at Stanford. I completed my MD-PhD training at Yale University and my residency training and a post-doctoral fellowship in the Department of Genetics at Stanford University. My experiences as a clinical pathologist and genome scientist have made me passionate about applying cutting-edge technologies to primary patient specimens in order to characterize disease pathologies at the molecular level. The core focus of my lab is to study the mechanisms by which genetic variants influence the risk of disease through effects on intermediate molecular phenotypes.
-
Michele Kastelein
Clinical Assistant Professor, Medicine - Vaden Health Center
Current Research and Scholarly InterestsAt Stanford University School of Medicine, one of our major goals is to translate research insights into practical advances that enhance and prolong life. We foster a two-way transfer of knowledge between research laboratories and patient-care settings. Our faculty, staff, postdoctoral scholars and students engage in interdisciplinary efforts to turn this knowledge into therapies that treat or prevent disease.
-
Tamiko Katsumoto
Clinical Associate Professor, Medicine - Immunology & Rheumatology
BioTamiko Katsumoto, MD, is a Clinical Associate Professor in the Division of Immunology and Rheumatology at Stanford University. She earned her MD from the University of California, San Francisco. She completed her internal medicine residency and rheumatology fellowship at UCSF, including a postdoc in the immunology lab of Dr. Arthur Weiss. Deeply committed to human and planetary health, she is passionate about educating her patients and colleagues on the merits of sustainable plant-rich diets as a strategy to both improve individual health and mitigate climate change and environmental degradation. She is fascinated by the impact of diet on inflammation and autoimmunity. She serves as the director of the Stanford Immune Related Toxicity Working Group, a multidisciplinary group which aims to improve the quality of care of cancer patients on immune checkpoint inhibitors. She has been investigating the impact of diet on immune-related adverse events. She is also intrigued by the relationship between cancer and autoimmune diseases, including diseases such as scleroderma and dermatomyositis, and the paraneoplastic manifestations of various cancers. She is involved in several clinical trials at Stanford and has spent time at Genentech, where she led several global clinical trials in immunology.
-
Daniel Katz
Instructor, Medicine - Cardiovascular Medicine
BioDaniel Katz is an Instructor of Medicine and an Advanced Heart Failure and Transplant Cardiologist. He completed internal medicine residency at Massachusetts General Hospital, general cardiology training at Beth Israel Deaconess Medical Center, and then joined Stanford in 2021 for his advanced heart failure training. Since medical school, his research has focused on identifying the various pathophysiologic patterns and mechanisms that lead to the heterogeneous syndrome of heart failure. His efforts leverage high dimensional data in many forms including clinical phenotypes, plasma proteomics, metabolomics, and genetics. He is presently engaged in analysis of multi-omic data from the Molecular Transducers of Physical Activity Consortium (MoTrPAC) and the NHLBI Trans-Omics for Precision Medicine (TOPMed) Program. His clinical interests include advanced heart failure, transplant cardiology, and mechanical circulatory support.
-
Colonel Ronit Katz (Ben-Abraham)
Clinical Professor (Affiliated), Primary Care and Population Health
Staff, Primary Care and Population HealthBioColonel (CA) Ronit Katz, MD is The Surgeon General for the CA Guard and a consultant to NASA-Ames Medical Unit. During the current pandemic she has played a vital leadership role in California’s response to the evolving situation and received two NASA-Ames safety awards for her role in COVID -19 prevention.
Professor Katz is Board Certified in Preventive, Occupational and Environmental Medicine, and is a Fellow of the American College of Preventive Medicine.
Dr. Katz provides her expertise in occupational and environmental medicine to the CA WRIISC team.
Colonel (Dr.) Katz attended Tel Aviv University and The Weizmann Institute of Science in Israel at age 15. She graduated Magna cum Laude from Tel Aviv University, Sackler Medical School. She completed a fellowship in cancer research at Tufts-New England Medical Center, and later served as a Faculty Member at the Harvard University School of Public Health.
She is a recipient of Lawrence Livermore National Lab's (LLNL) “Certificate of Excellence” for outstanding performance in support of the Health Services Department, received the NASA Group Achievement Award, and was selected as one of the "Top Doctors in Silicon Valley."
In 2007, Dr. Katz received The American Medical Association’s (AMA) “Excellence in Medicine and Leadership Award.”
She serves on many boards and committees for local and national professional organizations, including serving in various senior and policy leadership roles in the AMA including Chair of AMA-IMGS Governing council and Delegate to HOD, and representing Stanford University Medical center for AMA-OMSS.
In 2018, Dr. Katz was a keynote speaker at the JMA International Conference on CBRNE/Disaster Preparedness/Counterterrorism in preparation for the Tokyo 2020 Olympics. In 2019 Col. Katz was the Key note speaker for Lawrence Livermore National Lab (LLNL) and her presentation was streamed live to other DOE facilities.
Colonel Katz is a national speaker and educator for The American College of Occupational & Environmental Medicine( ACOEM) and The New England Journal of Medicine Resident 360 programs.
Colonel Katz, MD is a Clinical Professor(Aff.) at Stanford University Medical Center where she was awarded the "Excellent Teacher Award." -
Laurence Katznelson, MD
Professor of Neurosurgery and of Medicine (Endocrinology)
Current Research and Scholarly InterestsDr. Katznelson is an internationally known neuroendocrinologist and clinical researcher, with research expertise in the diagnosis and management of hypopituitarism, the effects of hormones on neurocognitive function, and the development of therapeutics for acromegaly and Cushings syndrome, and neuroendocrine tumors. Dr. Katznelson is the medical director of the multidisciplinary Stanford Pituitary Center, a program geared for patient management, clinical research and patient education
-
Rakshit Kaushik
Student Employee, Med/Quantitative Sciences Unit
BioHey there! I'm Rakshit Kaushik, hailing from the vibrant city of New Delhi, India. Embarking on my journey, I'm proudly joining the esteemed Stanford University as a member of the undergraduate class of '27. As I step into the realm of higher education, I'm eagerly poised to explore the realms of mathematics and computer science, both of which captivate my fervent interest.
Diving deep into my academic pursuits, I've been immersed in several enthralling research papers within the realm of mathematics. I take immense delight in blending the worlds of numbers and algorithms, where computer science plays a pivotal role. One such fascinating area I've delved into is Benford's law, uncovering its intricate connections to the digital realm.
Looking ahead, my aspirations soar as I strive to advance my research endeavors at Stanford, harnessing the incredible opportunities provided by programs such as SURIM and CURIS. These initiatives hold the promise of propelling my passion to new heights, enabling me to unravel more mysteries and push the boundaries of knowledge.
If you'd like to delve deeper into my projects and experiences, feel free to explore my LinkedIn profile at https://www.linkedin.com/in/rakshit-kaushik-93666a249/. I'd be delighted to connect and share more about my fascinating journey! -
Masataka Kawana
Assistant Professor of Medicine (Cardiovascular Medicine)
BioDr. Kawana joined the Advanced Heart Failure and Transplant Cardiology group in 2018. He completed his internal medicine, cardiovascular medicine, and heart failure training at Stanford. He also completed a postdoctoral research fellowship under Dr. James Spudich in the Department of Biochemistry. He sees advanced heart failure patients in the clinic and attends CCU/heart failure service, and post-heart transplant and MCS service. His research interests are in the fundamental mechanism of inherited cardiomyopathies, and he studies the effect of gene mutation on the cardiac sarcomere function using cutting-edge biochemical and biophysical approaches, which would lead to the development of novel pharmacotherapy that directly modulates cardiac muscle protein. He is involved in multiple clinical trials for pharmacotherapy in inherited cardiomyopathy and also conducting a device study in heart failure.
-
Vanessa Kennedy
Assistant Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
BioDr. Kennedy is a board-certified hematologist and medical oncologist who specializes in the treatment of myeloid malignancies, including acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), and myelofibrosis (MF). She is an Assistant Professor in the Department of Medicine, Division of Blood and Marrow Transplantation & Cellular Therapy, at Stanford University School of Medicine.
Dr. Kennedy conducts extensive research, ranging from interventional clinical trials to epidemiology studies. She also has expertise in the use of clinical informatics and bioinformatics in improving patient outcomes. Her work has been supported by grant funding from the American Society of Clinical Oncology, the American Society of Hematology, and the Chan-Zuckerberg Foundation. Her goal is to understand and improve outcomes in patients with myeloid malignancies. -
Rachel Keranen
Casual - Non-Exempt, Medicine
Current Role at StanfordWriter and Editor for the Chair
-
Kian Keyashian
Clinical Associate Professor, Medicine - Gastroenterology & Hepatology
BioThe management of inflammatory bowel disease continues to evolve, with the introduction of biologic and small molecule therapies and new goals of treatment, with an emphasis on healing the bowel. My career goal since my graduation from IBD fellowship in 2012 has been to improve the outcomes and quality of life of patients with inflammatory bowel disease. In line with these goals, my research has focused investigating new noninvasive diagnostic test, finding factors early in the disease course that might predict a more aggressive disease course and need for different therapies, and investigating new promising effective medications with less side effects.
-
Ali Raza Khaki, MD
Clinical Assistant Professor, Medicine - Oncology
BioDr. Khaki is a medical oncologist and clinical assistant professor at Stanford University School of Medicine.
In his clinical practice, he treats patients with all forms of genitourinary cancer, including kidney, bladder, prostate, and testicular. He also regularly attends on the inpatient oncology service at Stanford Hospital.
With each patient, he is devoted to providing exceptional, humanistic care and has been recognized throughout his career for his humanism. As a medical student, he was named to the national Gold Humanism Honor Society and he received the Reza Gandjei Humanism Award as a medical resident at UCSF.
His research interests include novel therapies for genitourinary cancers, with a focus on urothelial cancer outcomes. He also has studied health care utilization and costs for end-of-life care of cancer patients.
Dr. Khaki has earned honors and recognition from the American Association for Cancer Research, American Society of Clinical Oncology, Bladder Cancer Advocacy Network, Conquer Cancer Foundation, and other organizations.
He has authored numerous articles on topics such as immunotherapy for urothelial cancer, management of cancer patients with COVID-19, and utilization of end-of-life care by cancer patients. In addition, he is an editor for HemOnc.org and theMednet, a physician-only online community where members share clinical questions and answers. -
Saad A. Khan, MD
Assistant Professor of Medicine (Oncology)
BioDr. Khan is a fellowship-trained cancer specialist with board certification in oncology and hematology. He is an assistant professor in the Department of Medicine, Division of Oncology.
Dr. Khan focuses on the treatment of head and neck cancers, advanced thyroid cancers, and neuroendocrine tumors. He recognizes the broad effects of these conditions on daily living and aims to develop personalized, comprehensive treatment plans that optimize health and quality of life.
Dr. Khan’s research interests include therapeutic clinical trials as well as ways to reduce toxicities that some patients may experience when receiving cancer treatment. His research activities include ongoing clinical trials of targeted and immune therapy for aggressive thyroid cancer.
He has published numerous articles on his research discoveries in peer-reviewed journals such as the JAMA Oncology, Investigational New Drugs, and others. Topics include new drug treatments for small cell lung cancer and for cancers of the head and neck, racial and gender disparities in certain types of cancer, and management of the potentially toxic effects of cancer therapies.
Dr. Khan is a member of the NRG Head and Neck Committee. NRG brings together internationally recognized groups (the first words in their names form the acronym “NRG”) to conduct cancer clinical research and share study results. The objective is to inform clinical decision making and healthcare policy worldwide.
Dr. Khan is a member of the ECOG Head and Neck Core and Thoracic Committees. ECOG (Eastern Cooperative Oncology Group) is part of one of the five groups of the National Cancer Institute (NCI) National Clinical Trials Network (NCTN) Program.
He also is a member of the National Cancer Institute’s Central IRB for Early Phase Clinical Trials.
When not providing patient care or conducting research, Dr. Khan enjoys spending time with his family, hiking, and relaxing at the beach. -
Abha Khandelwal
Clinical Associate Professor, Medicine - Cardiovascular Medicine
Current Research and Scholarly InterestsCardiovascular disease in Pregnancy
Valvular Heart Disease
Cardiomyopathy
Pericardial disease
Heart Disease in South Asians
Women's Cardiovascular Disease -
Sarita Khemani
Clinical Associate Professor, Medicine
BioDr. Sarita Khemani is a Clinical Associate Professor of Medicine and a Neurosurgery Hospital Medicine physician. Her clinical focus is preventing and managing medical complications in hospitalized neurosurgical patients in the postoperative setting. Her interests include the intersection of medicine and technology to optimize a healthy lifespan.
Dr. Khemani is passionate about education and has served as Director of perioperative medicine rotations for Stanford medicine residents, medical students, and physician assistant students. She is the recipient of Department of Medicine Excellence in Teaching Award. Dr. Khemani is also the founder and co-director of Stanford Medicine Clinical Summer Internship, a globally recognized program for premed students. The program provides numerous scholarships to minority/underrepresented students to empower future leaders in medicine.
Dr. Khemani has been an invited speaker at various medical conferences and meetings. In addition, she was invited to speak at the Stanford Neurosurgery Grand Rounds and give the keynote speech at the Stanford Physician Assistant student graduation ceremony. She has appeared as a guest on various media outlets in the US and on international television.
Dr. Khemani is a member of the American College of Physicians and currently serves on the Stanford Hospital Pharmacy and Therapeutics Committee and Hospital Medicine Wellness Committee. -
Pik Fang Kho
Postdoctoral Scholar, Cardiovascular Medicine
BioI obtained my PhD in genetic epidemiology at Queensland University of Technology (Australia), where my research was focused on using genetic and genomic approaches to identify risk factors for endometrial cancer. During my graduate studies, I gained experience in large-scale genetic association studies and leveraging the correlation between diseases in genetic studies to identify novel genetic variants associated with endometrial cancer. I also developed expertise in various statistical genetic approaches in multi-omics data, including fine-mapping and colocalization analyses, to prioritize candidate causal variants and genes. I also gained extensive experience in genetic causal inference analysis to infer causality between risk factors and health outcomes.
My research focus since moving to Stanford has been the identification of genetic and non-genetic determinants of cardiometabolic diseases. I am currently involved in projects including large-scale genetic association studies, multi-trait analysis with correlated traits, development and validation of polygenic risk scores, integrative analyses with multi-omics data, as well as Mendelian randomization analyses to advance our understanding of the genetic and environmental factors that contribute to cardiometabolic diseases. -
Kiran Kaur Khush, MD
Professor of Medicine (Cardiovascular Medicine)
Current Research and Scholarly InterestsDr. Khush's clinical research interests include the evaluation of donors and recipients for heart transplantation; mechanisms of adverse outcomes after heart transplantation, including cardiac allograft vasculopathy and antibody-mediated rejection; and development of non-invasive diagnostic approaches for post-transplant monitoring.
-
Melanie Ann Kiener
Postdoctoral Medical Fellow, Infectious Diseases
BioI am an adult infectious disease fellow completing my post-doctoral research years in Dr. Desiree LaBeaud's lab. My research interests include global health epidemiology, infectious diseases diagnostics and global antimicrobial stewardship.
-
Michaela Kiernan
Sr Res Scholar, Medicine - Med/Stanford Prevention Research Center
Current Research and Scholarly InterestsResearch interests include: (1) the design and testing of targeted behavioral interventions that promote long-term lifestyle changes and weight management among subgroups at risk, and (2) the development of methodological and statistical approaches that improve the design, delivery, and analysis of behavioral randomized clinical trials
-
Joel Killen
Professor (Research) of Medicine (General Internal Medicine), Emeritus
Current Research and Scholarly InterestsMy research is focused on the development and evaluation of cigarette smoking prevention and cessation therapies and obesity prevention treatments for children, adolescents and adults.
-
Donghee Kim, MD, PhD
Social Science Research Scholar, Medicine - Med/Gastroenterology and Hepatology
BioI am clinically trained as a physician specializing in gastroenterology and hepatology. My research has focused on clinical research of nonalcoholic fatty liver disease (NAFLD) and obesity-related gastrointestinal diseases, focusing on a population-based study. In addition, my research was not only focused on gastroenterology and was expanded to cardiology, endocrinology, and neurology (sleep medicine). I have experience with large epidemiologic cohort studies as well as clinical trials. This work has resulted in over 250 published papers, including major journals such as Gastroenterology, Hepatology, Gut, Journal of Hepatology, American Journal of Gastroenterology, etc. (as the first and corresponding author). These publications have been cited more than 13,000 times.
-
Gloria S. Kim
Clinical Associate Professor, Medicine - Cardiovascular Medicine
Current Research and Scholarly InterestsMedical education
Health services delivery
Management of chronic disease
Patient and physician satisfaction -
Jackson Kim, MD
Clinical Assistant Professor, Medicine - Nephrology
BioDr. Kim is a Clinical Assistant Professor in the Division of Nephrology at Stanford Health Care.
Dr. Kim diagnoses and treats a range of conditions affecting the kidneys, including glomerulonephritis, nephrotic syndrome, chronic kidney disease, and genetic kidney disease. He creates a customized, comprehensive treatment plan for every patient he serves.
Dr. Kim has a keen research interest in glomerular kidney disease, particularly glomerulonephritis. He has authored manuscripts, conducted case studies, and published his work in several peer-reviewed journals. -
Juyong Brian Kim
Assistant Professor of Medicine (Cardiovascular Medicine)
Current Research and Scholarly InterestsThe lifetime risk of developing cardiovascular disease (CVD) is determined by the genetic makeup and exposure to modifiable risk factors. The Cardiovascular Link to Environmental ActioN (CLEAN) Lab is interested in understanding how various environmental pollutants (eg. tobacco, e-cigarettes, air pollution and wildfire) interact with genes to affect the transcriptome, epigenome, and eventually disease phenotype of CVD. The current focus is to investigate how different toxic exposures can adversely remodel the vascular wall leading to increased cardiac events. We intersect human genomic discoveries with animal models of disease, in-vitro and in-vivo systems of exposure, single-cell sequencing technologies to solve these questions. Additionally, we collaborate with various members of the Stanford community to develop biomarkers that will aid with detection and prognosis of CVD. We are passionate about the need to reduce the environmental effects on health through strong advocacy and outreach.
(http://kimlab.stanford.edu) -
Paige Livingston, PA-C
Temporary Employee, Medicine - Med/Blood and Marrow Transplantation
BioPaige has an undergraduate degree in Nutrition from Cal Poly, SLO and completed her Master’s degree in Physician Assistant Studies at Western University of Health Sciences in Southern California before moving to the bay area in November 2016 to join the Stanford Bone Marrow Transplant & Cancer Cell Therapy team. She believes in providing quality care with compassion, taking time to listen to patients and families and helping them navigate complex medical situations and decisions. She has lead the project for APP involvement in Bone Marrow Harvests and serves on the planning committee for a local APP Oncology conference. Her area of clinical practice is bone marrow transplantation and cancer cell therapy.
-
Seung K. Kim M.D., Ph.D.
KM Mulberry Professor, Professor of Developmental Biology, of Medicine (Endocrinology) and, by courtesy, of Pediatrics (Endocrinology)
Current Research and Scholarly InterestsWe study the development of pancreatic islet cells using molecular, embryologic and genetic methods in several model systems, including mice, pigs, human pancreas, embryonic stem cells, and Drosophila. Our work suggests that critical factors required for islet development are also needed to maintain essential functions of the mature islet. These approaches have informed efforts to generate replacement islets from renewable sources for diabetes.
-
Sun Kim, M.D. M.S.
Associate Professor of Medicine (Endocrinology)
Current Research and Scholarly InterestsWe are interested in studying the pathophysiological processes that contribute to glucose intolerance and type 2 diabetes mellitus. My current research focuses on characterizing pancreatic beta-cell function in populations with significant insulin resistance and vulnerability to developing diabetes: individuals with schizophrenia, morbid obesity, and history of gestational diabetes.
-
W. Ray Kim
Professor of Medicine (Gastroenterology and Hepatology)
BioChronic liver disease is one of the most common causes of premature death in Americans. My career goal is to improve the outcome of individuals with chronic liver disease by identifying the optimal means for diagnosis, monitoring, treatment and prevention. The path I have chosen to achieve this goal is through engagement in clinical epidemiology and patient-oriented, effectiveness research.
Since the development of the MELD score which recognizes the importance of renal function in the prognosis of patients with end stage liver disease, one of the areas that we have had intense interest has been acute and chronic renal injury in patients undergoing liver transplantation. Liver transplantation represents a unique opportunity for research, because of the potential for reversal of the renal injury as well as access to biological materials. -
Yeuen Kim
Adjunct Clinical Associate Professor, Medicine - Primary Care and Population Health
BioYeuen Kim MD MAS is an internal medicine physician with expertise in population health, medical humanities educational interventions, and working with vulnerable populations in urban settings. She trained at Brown University's Program in Liberal Medical Education (AB Comp Lit/French, MD) and completed residency/chief residency in internal medicine at the Santa Clara Valley Medical Center in 2000. She has worked with vulnerable populations in ambulatory and mobile settings as a primary care GMC attending and medical outreach physician, as well as completing a Masters' and fellowship in clinical research at UCSF's Department of Biostatistics and Epidemiology and SFGH DGIM, where she evaluated electronic referrals to subspecialty clinics from safety settings (Kim, Chen et al, JGIM 2009.) Since 2020, she has worked with the SF and Santa Clara County public health departments to help reduce mortality and improve C-19 and mpox mitigation, especially at residential congregate facilities through better ventilation, public-private collaboration, and addressing determinants of health for essential workers; she has summarized lessons learned from international conferences on COVID19 responses (Sales, Kim et al, AJPH 2021). Since 2013, she has facilitated art gallery-based workshops for physicians and learners to improve observation and communication skills. She co-leads narrative medicine and oncology workshops for medicine residents and students (Edwards, Kim et al, BMJ Educ 2022) and is an adjunct clinical associate professor in Primary care and population health, Medicine.
-
Youn H Kim, MD
The Joanne and Peter Haas, Jr., Professor for Cutaneous Lymphoma Research and Professor, by courtesy, of Medicine (Oncology)
Current Research and Scholarly InterestsClinical research in cutaneous lymphomas, especially, mycosis fungoides; studies of prognostic factors, long-term survival results, and effects of therapies. Collaborative research with Departments of Pathology and Oncology in basic mechanisms of cutaneous lymphomas. Clinical trials of new investigative therapies for various dermatologic conditions or clinical trials of known therapies for new indications.
-
Abby C. King
David and Susan Heckerman Professor and Professor of Epidemiology & Population Health and of Medicine (Stanford Prevention Research Center)
Current Research and Scholarly InterestsMy interests include applications of behavioral theory and social ecological approaches to achieve large scale changes impacting chronic disease prevention and control; expanding the reach and translation of evidence-based interventions through state-of-the-art technologies; exploring social and physical environmental influences on health; applying community participatory research perspectives to address health disparities; and policy-level approaches to health promotion/disease prevention.
-
David Kinitz
Postdoctoral Scholar, Nephrology
BioDavid J. Kinitz, PhD, MSW is a social and behavioural health scientist and social worker with a passion for understanding the complex social, political, and economic systems that shape LGBTQ+ mental health and wellbeing. David holds a PhD in Social and Behavioural Health Sciences from the Dalla Lana School of Public Health, University of Toronto, and graduate and undergraduate degrees in social work from York University and Lakehead University, respectively. His work primarily draws on critical qualitative and mixed-methods methodologies to deconstruct systems of oppression, such as racism, cissexism, heterosexism, and classism. He looks at how these systems reinforce social hierarchies that produce ill-health, particularly as they relate to labour market phenomena. David’s doctoral research employed narrative inquiry and Marxist political economy theories to study economic insecurity, precarious employment, and mental health among gay, bisexual, and queer men in Toronto, Canada. David continues this area of scholarship through leading and collaborating on various projects exploring access to social assistance, employment quality, employment skills and training, and economic insecurity among LGBTQ+ people in Canada and the US.
-
Teri Klein
Professor (Research) of Biomedical Data Science, of Medicine (BMIR) and, by courtesy, of Genetics
Current Research and Scholarly InterestsCo-founder, Pacific Symposium on Biocomputing
NIEHS, Site Visit Reviewer
NIH, Study Section Reviewer -
Samantha M.R. Kling
Quantitative Research Scientist, Primary Care and Population Health
Current Role at StanfordQuantitative Research Scientist in the Evaluation Sciences Unit (ESU)
-
Joshua W. Knowles
Associate Professor of Medicine (Cardiovascular Medicine)
Current Research and Scholarly InterestsGenetic basis of coronary disease
Genetic basis of insulin resistance
Familial Hypercholesterolemia (FH)
